BDBM590846 (R)-N-(1-(4-cyanophenyl)ethyl)-6-cyclopropyl-1- (4-fluorobenzyl)-2-oxo-1,2-dihydro-1,8-naphthyridine- 3-carboxamide::US11564928, Compound 95

SMILES C[C@@H](NC(=O)c1cc2cc(cnc2n(Cc2ccc(F)cc2)c1=O)C1CC1)c1ccc(cc1)C#N

InChI Key InChIKey=JNLRAPCLPDURHR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590846   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590846(US11564928, Compound 95 | (R)-N-(1-(4-cyanophenyl)...)
Affinity DataIC50: 3.20nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590846(US11564928, Compound 95 | (R)-N-(1-(4-cyanophenyl)...)
Affinity DataIC50: 895nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent